Hong T H, Hsiao S C, Sheu W J, Chang T H
Cell Biology and Immunology Division, Development Center for Biotechnology, Taipei, Taiwan, R.O.C.
Hybridoma. 1992 Jun;11(3):339-50. doi: 10.1089/hyb.1992.11.339.
alpha-Fetoprotein (AFP) is a well-known tumor marker of hepatocellular carcinoma (HCC). Monoclonal antibodies against AFP possessing specific binding ability to HCC are potential candidates for immunoscintigraphy and immunotherapy. A new monoclonal antibody against AFP (0325-6-9) was isolated. Its specificity and targeting tumor ability were characterized by enzyme-linked immunosorbent assay (ELISA), cell immunostain and complement killing. These results suggest that 0325-6-9 is specific to hepatoma cells. The nucleotide sequences of variable regions of 0325-6-9 were determined by M13 dideoxynucleotide sequencing method. With the information of nucleotide sequence, this antibody then could be modified by recombinant technology for its usage in in vivo diagnosis and immunotherapy.
甲胎蛋白(AFP)是一种广为人知的肝细胞癌(HCC)肿瘤标志物。对HCC具有特异性结合能力的抗AFP单克隆抗体是免疫闪烁造影和免疫治疗的潜在候选物。一种新的抗AFP单克隆抗体(0325-6-9)被分离出来。通过酶联免疫吸附测定(ELISA)、细胞免疫染色和补体杀伤来表征其特异性和靶向肿瘤的能力。这些结果表明0325-6-9对肝癌细胞具有特异性。采用M13双脱氧核苷酸测序法测定了0325-6-9可变区的核苷酸序列。根据核苷酸序列信息,然后可以通过重组技术对该抗体进行修饰,以用于体内诊断和免疫治疗。